The SmartFlow Neuro Cannula is intended for intraputaminal administration of PTC Therapeutics’ gene therapy KEBILIDI for the treatment of aromatic L-amino acid decarboxylase deficiency.

The SmartFlow Neuro Cannula has received De Novo FDA approval for the intraputaminal administration of the gene therapy KEBILIDI™ (eladocagene exuparvovec-tneq) for the treatment of aromatic L ...

The treatments were performed at a leading healthcare institution in the southeastern United States using the same Aquadex SmartFlow ® system and clinical protocols trusted in inpatient environments.

(Nasdaq: NUWE), a medical technology company focused on fluid management, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new size of its Dual Lumen ...

The company is focused on commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, with a wholly owned subsidiary in Ireland.

About the Aquadex SmartFlow® System The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible and smart method of removing excess fluid from patients suffering from ...

The company is focused on commercializing the Aquadex SmartFlow ® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, with a wholly owned subsidiary in Ireland.